Abstract
Objective To explore the effect and application value of retinal photocoagulant combined with compound anisodine in the treatment of diabetic retinopathy, and its effect on vascular endothelial growth factor (VEGF) and insulin-like growth factor-1(IGF-1) level. Methods 116 patients with diabetic retinopathy were selected, and they were randomly divided into observation group and control group according to the digital table, 58 cases in each group.The control group was given retinal photocoagulation treatment, and the observation group was given retinal photocoagulation combined with compound anisodine treatment.The therapeutic effect was compared between the two groups. Results The total effective rate of the observation group was 93.10%, which was significantly higher than 77.59% of the control group, and the difference between the two groups was statistically significant (χ2=5.582, P<0.05). The edema absorption time, bleeding absorption time, exudate absorption time of the observation group were (4.19±1.24)d, (2.19±1.01)d, (9.48±2.13)d, respectively, which of the control group were (5.83±2.85)d, (3.25±1.88)d, (13.54±3.88)d, respectively, and the differences between the two groups were statistically significant (t=4.018, 3.782, 6.985, all P<0.05). After treatment, the VEGF and IGF-1 levels in the observation group were (85.12±4.64)ng/L, (90.17±4.95)μg/L, respectively, which in the control group were (100.48±9.26)ng/L, (132.69±10.04)μg/L, respectively, the differences between the two groups were statistically significant (t=11.294, 28.928, all P<0.05). Conclusion Retinal photocoagulation surgery combined with compound anisodine in the treatment of diabetic retinopathy can improve clinical curative effect, promote the patients' visual acuity, adjust the concentration of VEGF, the effect is remarkable, it is worthy of popularizing in clinical application. Key words: Laser coagulation; Diabetic retinopathy; Vascular endothelial growth factors; Insulin-like growth factor-1
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.